U.S. Markets closed

Aziyo Biologics, Inc. (AZYO)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
15.93+0.12 (+0.76%)
At close: 4:00PM EST

15.93 0.00 (0.00%)
After hours: 4:00PM EST

Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 318.20
52 Week Low 310.55
50-Day Moving Average 313.78
200-Day Moving Average 312.96

Share Statistics

Avg Vol (3 month) 338.19k
Avg Vol (10 day) 312.77k
Shares Outstanding 57.09M
Float 2.42M
% Held by Insiders 19.02%
% Held by Institutions 159.88%
Shares Short (Dec 30, 2020) 4221.93k
Short Ratio (Dec 30, 2020) 44.89
Short % of Float (Dec 30, 2020) 47.44%
Short % of Shares Outstanding (Dec 30, 2020) 42.17%
Shares Short (prior month Nov 29, 2020) 4194.68k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020

Profitability

Profit Margin -45.54%
Operating Margin (ttm)-30.39%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)42.27M
Revenue Per Share (ttm)4.69
Quarterly Revenue Growth (yoy)5.70%
Gross Profit (ttm)19.77M
EBITDA -8.95M
Net Income Avi to Common (ttm)-22.76M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.54M
Total Cash Per Share (mrq)0.15
Total Debt (mrq)29.96M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.87
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-10.83M
Levered Free Cash Flow (ttm)N/A